Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The therapeutic and preventive activities of retinoids in cancer are due to their ability to modulate the growth, differentiation, and survival or apoptosis of cancer cells. Here we show that in NB4 acute promyelocytic leukemia cells, retinoids selective for retinoic-acid receptor-alpha induced an autoregulatory circuitry of survival programs followed by expression of the membrane-bound tumor-selective death ligand, TRAIL (tumor necrosis factor-related apoptosis-inducing ligand, also called Apo-2L). In a paracrine mode of action, TRAIL killed NB4 as well as heterologous and retinoic-acid-resistant cells. In the leukemic blasts of freshly diagnosed acute promyelocytic leukemia patients, retinoic-acid-induced expression of TRAIL most likely caused blast apoptosis. Thus, induction of TRAIL-mediated death signaling appears to contribute to the therapeutic value of retinoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
International Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
The Receptor for the Cytotoxic Ligand TRAIL
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,767
Programmed Cell Death and the Control of Cell Survival: Lessons from the Nervous System
Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y., & Jacobson, M. D. (1993) · Science · doi:10.1126/science.8235590 · Cited by 1,460
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,288
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
Cited by
Items 101–200 of 371
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. “Vitelotte”
Bontempo, P., Masi, L. D., Carafa, V., Rigano, D., Scisciola, L., Iside, C., Grassi, R., Molinari, A. M., Aversano, R., Nebbioso, A., et al. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.09.063 · Cited by 70
Self-citationTourneur, L., Buzyn, A., & Chiocchia, G. (2005) · Medical Immunology · doi:10.1186/1476-9433-4-1 · Cited by 63
Su, D., & Gudas, L. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.006 · Cited by 68
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues
García, J. L., Franci, G., Pereira, R., Benedetti, R., Nebbioso, A., Rodríguez‐Barrios, F., Gronemeyer, H., Altucci, L., & de Lera, Á. R. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.026 · Cited by 66
Self-citationKaminski, B. M., Weigert, A., Brüne, B., Schumacher, M., Wenzel, U., Steinhilber, D., Stein, J. M., & Ulrich, S. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1413-y · Cited by 64
Implications of apoptosis regulators in tumorigenesis
Malaguarnera, L. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031774.32572.df · Cited by 64
Acute myeloid leukemia: Therapeutic impact of epigenetic drugs
Altucci, L., Clarke, N., Nebbioso, A., Scognamiglio, A., & Gronemeyer, H. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.019 · Cited by 64
Self-citationBernardo, A. R., Cosgaya, J. M., Aranda, A., & Jimenez-Lara, A. M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.5 · Cited by 63
Retinoids as a potential treatment for experimental puromycin‐induced nephrosis
Moreno‐Manzano, V., Mampaso, F. M., Sepúlveda-Muñoz, J. C., Alique, M., Chen, S., Ziyadeh, F. N., de la Cruz, M. D. C. I., Rodríguez, J., Nieto, E. O., Orellana, J. M., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705311 · Cited by 63
TRAIL/TRAIL‐R in hematologic malignancies
Testa, U. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22549 · Cited by 62
TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription
Sato, T. Z., Okumura, F., Kano, S., Kondo, T., Ariga, T., & Hatakeyama, S. (2011) · Journal of Cell Science · doi:10.1242/jcs.088799 · Cited by 62
Souto, J. A., Conte, M., Álvarez, R., Nebbioso, A., Carafa, V., Altucci, L., & de Lera, Á. R. (2008) · ChemMedChem · doi:10.1002/cmdc.200800096 · Cited by 61
Self-citationJohnston, J. B., Kaboré, A. F., Strutinsky, J., Hu, X., Paul, J. T., Kropp, D. M., Kuschak, B., Begleiter, A., & Gibson, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1207004 · Cited by 60
Synthesis and Biological Properties of Novel, Uracil-Containing Histone Deacetylase Inhibitors
Mai, A., Massa, S., Rotili, D., Simeoni, S., Ragno, R., Botta, G., Nebbioso, A., Miceli, M., Altucci, L., & Brosch, G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0605536 · Cited by 60
Self-citationRasooly, R., Schuster, G. U., Gregg, J. P., Xiao, J. H., Chandraratna, R. A. S., & Stephensen, C. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7916 · Cited by 59
Retinoic-acid-induced apoptosis in leukemia cells
Jimenez-Lara, A. M., Clarke, N., Altucci, L., & Gronemeyer, H. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.08.006 · Cited by 59
Self-citationRahmani, M., Dai, Y., & Grant, S. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5548 · Cited by 59
Leiva, M., Moretti, S., Soilihi, H., Pallavicini, I., Peres, L., Mercurio, C., Dal Zuffo, R., Minucci, S., & de Thé, H. (2012) · Leukemia · doi:10.1038/leu.2012.39 · Cited by 58
Billottet, C., Banerjee, L., Vanhaesebroeck, B., & Khwaja, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2608 · Cited by 58
Differential Retinoic Acid Signaling in Tumors of Long- and Short-term Glioblastoma Survivors
Barbus, S., Tews, B., Karra, D., Hahn, M., Radlwimmer, B., Delhomme, N., Hartmann, C. J., Felsberg, J., Krex, D., Schackert, G., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr036 · Cited by 58
Meng, X. W., Chandra, J., Loegering, D., Van Becelaere, K., Kottke, T. J., Gore, S. D., Karp, J. E., Sebolt-Leopold, J., & Kaufmann, S. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304793200 · Cited by 54
On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils
Cassatella, M. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005558 · Cited by 57
BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients
Carvalho, D. D. D., Binato, R., Pereira, W. O., Leroy, J. M. G., Colassanti, M. D., Proto‐Siqueira, R., Bueno-da-Silva, A. E. B., Zago, M. A., Zanichelli, M. A., Abdelhay, E. S. F. W., et al. (2010) · Oncogene · doi:10.1038/onc.2010.409 · Cited by 56
Kurmi, B. D., Patel, P., Paliwal, R., & Paliwal, S. R. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101682 · Cited by 55
HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2
Scognamiglio, A., Nebbioso, A., Manzo, F., Valente, S., Mai, A., & Altucci, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.007 · Cited by 55
Self-citationPhysiological and pathological implications of retinoid action in the endometrium
Jiang, Y., Chen, L., Taylor, R. N., Li, C., & Zhou, X. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0544 · Cited by 54
Kikuchi, S., Nagai, T., Kunitama, M., Kirito, K., Ozawa, K., & Komatsu, N. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00623.x · Cited by 54
Nuclear receptor superfamily: Principles of signaling
Germain, P., Altucci, L., Bourguet, W., Rochette-Egly, C., & Gronemeyer, H. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375111619 · Cited by 53
“In addition to the induction of antiapoptotic and survival programs, ATRA induces postmaturation apoptosis through the induction of TRAIL [263], a tumor-selective death ligand [264], as well as caspase 8/10 that mediate TRAIL action through the cognate DR5 receptor.”
BackgroundSelf-citationBispyridinium Dienes: Histone Deacetylase Inhibitors with Selective Activities
Pérez-Balado, C., Nebbioso, A., Rodríguez-Graña, P., Minichiello, A., Miceli, M., Altucci, L., & de Lera, Á. R. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070028m · Cited by 48
Self-citationBleul, T., Rühl, R., Bulashevska, S., Karakhanova, S., Werner, J., & Bazhin, A. V. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22158 · Cited by 52
Cell Cycle Regulation and Induction of Apoptosis by β-carotene in U937 and HL-60 Leukemia Cells
Upadhyaya, K. R., Radha, K. S., & Madhyastha, H. K. (2007) · BMB Reports · doi:10.5483/bmbrep.2007.40.6.1009 · Cited by 47
Wang, R., Xia, L., Gabrilove, J. L., Waxman, S., & Jing, Y. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0663 · Cited by 51
Chromatin Modification, Leukaemia and Implications for Therapy
Jones, L. K., & Saha, V. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03586.x · Cited by 51
Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets
Crist, S. A., Elzey, B. D., Ludwig, A. T., Griffith, T. S., Staack, J. B., Lentz, S. R., & Ratliff, T. L. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.07.022 · Cited by 51
Wang, J., Peng, Y., Sun, Y. W., He, H., Zhu, S., An, X., Li, M., Lin, M. C. M., Zou, B., Xia, H. H., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.017 · Cited by 50
Dhandapani, L., Yue, P., Ramalingam, S. S., Khuri, F. R., & Sun, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4180 · Cited by 49
The effect of regulating molecules on the structure of the PPAR-RXR complex
Amber-Vitos, O., Chaturvedi, N., Nachliel, E., Gutman, M., & Tsfadia, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.003 · Cited by 48
Yoshida, T., Horinaka, M., Takara, M., Tsuchihashi, M., Mukai, N., Wakada, M., & Sakai, T. (2008) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-008-0041-1 · Cited by 48
Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives
Ortiz, M. A., Bayón, Y., López-Hernández, F. J., & Piedrafita, F. J. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00050-x · Cited by 48
Cartee, L., Smith, R. L., Dai, Y., Rahmani, M., Rosato, R. R., Almenara, J. A., Dent, P., & Grant, S. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12090-1 · Cited by 48
Mechanisms of Selective Anticancer Action of Histone Deacetylase Inhibitors
Insinga, A., Minucci, S., & Pelicci, P. G. (2005) · Cell Cycle · doi:10.4161/cc.4.6.1717 · Cited by 47
Eriksson, M., Peña‐Martínez, P., Ramakrishnan, R., Chapellier, M., Högberg, C., Glowacki, G., Orsmark‐Pietras, C., Velasco-Hernández, T., Lazarević, V., Juliusson, G., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017006148 · Cited by 47
A Novel Retinoic Acid-Responsive Element Regulates Retinoic Acid-Induced BLR1 Expression
Wang, J., & Yen, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2423-2443.2004 · Cited by 47
Xia, L., Wurmbach, E., Waxman, S., & Jing, Y. (2006) · Leukemia · doi:10.1038/sj.leu.2404198 · Cited by 46
Liu, D., Li, M., Zhao, Z., Zhou, L., Zhi, F., Guo, Z., & Cui, J. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3971 · Cited by 45
The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1
Jenal, M., Batliner, J., Reddy, V. A., Haferlach, T., Tobler, A., Fey, M. F., Torbett, B. E., & Tschan, M. P. (2010) · Leukemia · doi:10.1038/leu.2010.26 · Cited by 45
Pathogenesis, Diagnosis and Monitoring of Residual Disease in Acute Promyelocytic Leukaemia
Reiter, A., Lengfelder, E., & Grimwade, D. J. (2004) · Acta Haematologica · doi:10.1159/000077560 · Cited by 45
Cicero, A. L., Jaskowiak, A.-L., Egesipe, A.-L., Tournois, J., Brinon, B., Pitrez, P. R., Ferreira, L., Sandre‐Giovannoli, A. D., Lévy, N., & Nissan, X. (2016) · Scientific Reports · doi:10.1038/srep34798 · Cited by 44
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells
Bontempo, P., Mita, L., Doto, A., Miceli, M., Nebbioso, A., Lepore, I., Franci, G., Menafra, R., Carafa, V., Conte, M., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-48 · Cited by 44
Self-citationCuello, M. A., Coats, A. O., Darko, I., Ettenberg, S. A., Gardner, G. J., Nau, M. M., Liu, J. R., Birrer, M. J., & Lipkowitz, S. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401387 · Cited by 44
Revisiting the Role of TRAIL/TRAIL-R in Cancer Biology and Therapy
Singh, D., Tewari, M., Singh, S., & Narayan, G. (2021) · Future Oncology · doi:10.2217/fon-2020-0727 · Cited by 43
Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM
Yin, W., Rossin, A., Clifford, J. L., & Gronemeyer, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209410 · Cited by 43
Self-citationRotili, D., Carafa, V., Tarantino, D., Botta, G., Nebbioso, A., Altucci, L., & Mai, A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.025 · Cited by 42
Self-citationMEK blockade converts AML differentiating response to retinoids into extensive apoptosis
Milella, M., Konopleva, M. Y., Precupanu, C., Tabe, Y., Ricciardi, M. R., Gregorj, C., Collins, S. J., Carter, B. Z., D’Angelo, C., Petrucci, M. T., et al. (2006) · Blood · doi:10.1182/blood-2006-05-024679 · Cited by 42
Navakauskienė, R., Treigytė, G., Gineitis, A. A., & Magnusson, K. (2004) · PROTEOMICS · doi:10.1002/pmic.200300671 · Cited by 42
Hematopoiesis and Retinoids: Development and Disease
Oren, T., Sher, J. A., & Evans, T. (2003) · Leukemia & Lymphoma · doi:10.1080/1042819031000116661 · Cited by 39
Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia
Przespolewski, A., & Wang, E. S. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1175432 · Cited by 40
Jin, C.-J., Hong, C. Y., Takei, M., Chung, S.-Y., Park, J., Pham, T.-N. N., Choi, S.-J.-N., Nam, J., Chung, I., Kim, H., et al. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.10.006 · Cited by 40
Gobbi, G., Mirandola, P., Carubbi, C., Micheloni, C., Malinverno, C., Lunghi, P., Bonati, A., & Vitale, M. (2008) · Blood · doi:10.1182/blood-2008-03-143784 · Cited by 40
Coyle, K. M., Maxwell, S. P., Thomas, M. L., & Marcato, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-16687-6 · Cited by 40
Luca, A. D., Baldi, A., Russo, P., Todisco, A., Altucci, L., Giardullo, N., Pasquale, L., Iaquinto, S., D’Onofrio, V., Parodi, M. C., et al. (2003) · PubMed · Cited by 39
Self-citationBellis, F. D., Carafa, V., Conte, M., Rotili, D., Petraglia, F., Matarese, F., Françoijs, K., Ablain, J., Valente, S., Castellano, R., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2568 · Cited by 38
Self-citationChemopreventive agent-induced modulation of death receptors
Sun, S. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2274-4 · Cited by 37
Retinoid Signaling in Cancer and Its Promise for Therapy
Coyle, K. M. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s7-006 · Cited by 36
Conserva, M. R., Anelli, L., Zagaria, A., Specchia, G., & Albano, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122921 · Cited by 35
Rivera-Gonzalez, G. C., Droop, A., Rippon, H. J., Tiemann, K., Pellacani, D., Georgopoulos, L. J., & Maitland, N. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks143 · Cited by 35
Savickienė, J., Treigytė, G., Stirblytė, I., Valiulienė, G., & Navakauskienė, R. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.04.003 · Cited by 35
Density of points clustering, application to transcriptomic data analysis
Wicker, N., Dembélé, D., Raffelsberger, W., & Poch, O. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf511 · Cited by 35
Self-citationLi, J., Orr, B., White, K., Belogortseva, N., Niles, R. M., Bošković, G., Nguyen, H., Dykes, A. C., & Park, M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-7 · Cited by 35
Greil, R., Anether, G., Jöhrer, K., & Tinhofer, I. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0802416 · Cited by 35
Spalding, A. C., Jotte, R. M., Scheinman, R. I., Geraci, M. W., Clarke, P., Tyler, K. L., & Johnson, G. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205048 · Cited by 35
Zhou, N., Yao, Y., Ye, H., Zhu, W. P., Chen, L., & Mao, Y. Q. (2015) · International Journal of Cancer · doi:10.1002/ijc.29935 · Cited by 34
Antiproliferative and apoptotic activities of 8-prenylnaringenin against human colon cancer cells
Koosha, S., Mohamed, Z., Sinniah, A., Ibrahim, Z. A., Seyedan, A., & Alshawsh, M. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116633 · Cited by 34
Noack, K., Mahendrarajah, N., Hennig, D., Schmidt, L., Grebien, F., Hildebrand, D., Christmann, M., Kaina, B., Sellmer, A., Mahboobi, S., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1878-5 · Cited by 33
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer
Ebrahimi, N., Parkhideh, S., Samizade, S., Esfahani, A. N., Samsami, S., Yazdani, E., Adelian, S., Chaleshtori, S. R., Shahamiri, K., Ahmadi, A., et al. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.04.003 · Cited by 33
Soncini, M., Santoro, F., Gutiérrez, A., Frigè, G., Romanenghi, M., Botrugno, O. A., Pallavicini, I., Pelicci, P. G., Croce, L. D., & Minucci, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.001 · Cited by 33
Blagitko‐Dorfs, N., Jiang, Y., Duque‐Afonso, J., Hiller, J. K., Yalcin, A., Greve, G., Abdelkarim, M., Hackanson, B. W., & Lübbert, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075258 · Cited by 32
Potential role of retinoids in ovarian physiology and pathogenesis of polycystic ovary syndrome
Jiang, Y., Li, C., Chen, L., Wang, F., & Zhou, X. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.03.025 · Cited by 31
New Conjunctive Reagents as Cross-Coupling Partners En Route to Retinoid-like Polyenes
Lipshutz, B. H., Clososki, G. C., Chrisman, W., Chung, D. W., Ball, D. B., & Howell, J. (2005) · Organic Letters · doi:10.1021/ol051406p · Cited by 31
Mai, A., Perrone, A., Nebbioso, A., Rotili, D., Valente, S., Tardugno, M., Massa, S., Bellis, F. D., & Altucci, L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.055 · Cited by 31
Self-citationDifferentiation induction as a treatment for hematologic malignancies
Miller, W. H., & Waxman, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205328 · Cited by 31
Iizuka-Ohashi, M., Watanabe, M., Sukeno, M., Morita, M., Hoang, N. T. H., Kuchimaru, T., Kizaka‐Kondoh, S., Sowa, Y., Sakaguchi, K., Taguchi, T., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24696 · Cited by 30
Savickienė, J., Treigytė, G., Borutinskaite, V. V., & Navakauskienė, R. (2012) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-012-0024-5 · Cited by 30
Sacha, T., Zawada, M., Hartwich, J., Lach, Z., Polus, A., Szostek, M., Zdziƚowska, E., Libura, M. A., Bodzioch, M., Dembinska-Kiec, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.12.005 · Cited by 30
Therapeutic Effect of Retinoic Acid on Unilateral Ureteral Obstruction Model
Kishimoto, K., Kinoshita, K., Hino, S., Yano, T., Nagare, Y., Shimazu, H., Nozaki, Y., Sugiyama, M., Ikoma, S., & Funauchi, M. (2011) · Nephron Experimental Nephrology · doi:10.1159/000322409 · Cited by 29
Genista sessilifolia DC . extracts induce apoptosis across a range of cancer cell lines
Bontempo, P., Rigano, D., Doto, A., Formisano, C., Conte, M., Nebbioso, A., Carafa, V., Caserta, G., Sica, V., Molinari, A. M., et al. (2013) · Cell Proliferation · doi:10.1111/cpr.12022 · Cited by 29
Self-citationJimenez-Lara, A. M., Aranda, A., & Gronemeyer, H. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-15 · Cited by 29
Self-citationThe Role of Forkhead Box Proteins in Acute Myeloid Leukemia
Gurnari, C., Falconi, G., Bellis, E. D., Voso, M. T., & Fabiani, E. (2019) · Cancers · doi:10.3390/cancers11060865 · Cited by 29
Mathieu, J., Giraudier, S., Lanotte, M., & Besançon, F. (2005) · Oncogene · doi:10.1038/sj.onc.1208889 · Cited by 28
Wu, Y., Wang, X.-L., Liu, J.-H., Bao, Z.-J., Tang, D., Wu, Y., & Zeng, S. (2011) · Theriogenology · doi:10.1016/j.theriogenology.2011.06.016 · Cited by 28
Mai, A., Valente, S., Nebbioso, A., Simeoni, S., Ragno, R., Massa, S., Brosch, G., Bellis, F. D., Manzo, F., & Altucci, L. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.002 · Cited by 28
Self-citationJasek-Gajda, E., Mirecka, J., & Litwin, J. A. (2008) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0080-x · Cited by 28
Cross-talk Between Retinoic Acid and STAT3 Signaling Pathways in Acute Promyelocytic Leukemia
Dong, S., Chen, S., & Tweardy, D. J. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000116670 · Cited by 28
Maquarre, E., Artus, C., Gadhoum, Z., Jasmin, C., Smadja‐Joffe, F., & Robert-Lézénès, J. (2005) · Leukemia · doi:10.1038/sj.leu.2403944 · Cited by 28
The molecular basis of retinoid action in tumors
Merino, R., & Hurlé, J. M. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.10.003 · Cited by 26
Kalli, K. R., Devine, K. E., Cabot, M. C., Arnt, C. R., Heldebrant, M. P., Svingen, P. A., Erlichman, C., Hartmann, L. C., Conover, C. A., & Kaufmann, S. H. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1434 · Cited by 26
Leukemia: beneficial actions of retinoids and rexinoids
Altucci, L., Wilhelm, E., & Gronemeyer, H. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00247-4 · Cited by 26
Self-citationThe emergence of resistance to targeted cancer therapeutics
Mellinghoff, I. K., & Sawyers, C. L. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.5.603 · Cited by 26
Apoptosis and immaturity in acute myeloid leukemia
Principe, M. I. D., Poeta, G. D., Venditti, A., Buccisano, F., Maurillo, L., Mazzone, C., Bruno, A., Neri, B., Consalvo, M. I., Lo‐Coco, F., et al. (2005) · Hematology · doi:10.1080/10245330400020454 · Cited by 26
Chebaro, Y., Amal, I., Rochel, N., Rochette-Egly, C., Stote, R. H., & Dejaegere, A. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003012 · Cited by 25
“Nuclear receptors are ligand-dependent transcription factors that participate in many cellular signaling networks involved in various physiological phenomena, such as embryogenesis, cell differentiation, cell growth, reproduction and apoptosis [1].”
Background
Metadata
- Authors
- Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C., & Gronemeyer, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Hôpital Saint-Louis (FR)
- Corresponding author
- Gronemeyer, Hinrich
- Venue
- Nature Medicine
- Published
- 2001-06
- Volume
- 7
- Issue
- 6
- Pages
- 680-686
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1551972473
- Cited by
- 340
- References
- 47
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 7 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 14 · 2016: 6 · 2015: 8 · 2014: 12 · 2013: 9 · 2012: 10
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- retinoic acid, retinoids, TRAIL, apoptosis, acute promyelocytic leukemia, NB4 cells, retinoic acid receptor alpha, paracrine signaling, retinoic acid resistance, leukemia cell survival
- MeSH terms
- Arsenic Trioxide, Antineoplastic Agents, Arsenicals, Cell Differentiation, Humans, Membrane Glycoproteins, Neoplasm Proteins, Oxides, Proteins, Recombinant Fusion Proteins, Tretinoin, Tumor Cells, Cultured, Tumor Necrosis Factor-alpha, Immunoblotting, Signal Transduction, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, NF-kappa B, Apoptosis, Receptors, Tumor Necrosis Factor, Coculture Techniques, Paracrine Communication, Caspases, TNF Receptor-Associated Factor 1, Apoptosis Regulatory Proteins, Inhibitor of Apoptosis Proteins, TNF-Related Apoptosis-Inducing Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.